| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| naringenin | aldo-keto reductase family 1 member c1 | small molecule | NA | drugbank | NA | NA | experimental | antagonist |
| naringenin | cytochrome p450 19a1 | small molecule | NA | drugbank , DGIDB | NA | 0.44 | experimental | inhibitor |
| naringenin | aromatase | NA | Successful target | TTD , DGIDB | NA | 0.44 | phase 1 | unknown |
| naringenin | cytochrome p450 1b1 | small molecule | Clinical trial target | TTD , drugbank , DGIDB | NA | 0.57 | experimental,phase 1 | unknown |
| naringenin | estrogen receptor alpha | small molecule | NA | drugbank | NA | NA | experimental | unknown |
| naringenin | estrogen receptor beta | small molecule | Successful target | TTD , drugbank , DGIDB | NA | 0.23 | experimental,phase 1 | partial agonist |
| naringenin | lactoylglutathione lyase | NA | Clinical trial target | TTD , DGIDB | NA | 3.98 | phase 1 | unknown |
| naringenin | estradiol 17 beta-dehydrogenase 1 | NA | Clinical trial target | TTD | NA | NA | phase 1 | unknown |
| naringenin | kat8 regulatory nsl complex subunit 3 | small molecule | NA | drugbank | NA | NA | experimental | unknown |
| naringenin | sex hormone-binding globulin | small molecule | NA | drugbank | NA | NA | experimental | unknown |
| click here to return to the previous page | ||||||||